MTIP
AGTC

Magee Thomson Investment Partners’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Magee Thomson Investment Partners’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-44
Closed -$1K – 103
2016
Q2 		$1K Sell
44
-218
-83% -$3.4K ﹤0.01% 69
2016
Q1 		$4K Hold
262
– – ﹤0.01% 76
2015
Q4 		$5K Hold
262
– – ﹤0.01% 58
2015
Q3 		$4K Hold
262
– – ﹤0.01% 83
2015
Q2 		$4K Sell
262
-56
-18% -$1.07K ﹤0.01% 95
2015
Q1 		$6K Buy
318
+32
+11% +$716 ﹤0.01% 49
2014
Q4 		$5K Buy
+286
New +$5.82K ﹤0.01% 126

Other funds holding AGTC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Magee Thomson Investment Partners's AGTC Position: Q3 2016 in Review

Magee Thomson Investment Partners sold out of Applied Genetic Technologies Corporation (AGTC) in Q3 2016, closing a stake of 44 shares — an estimated $1K sold.

Magee Thomson Investment Partners first reported a position in AGTC in Q4 2014 and held it in 7 quarters. The position peaked at $6K in Q1 2015. 95 funds tracked by Wall St. Rank hold AGTC as of Q3 2016.

  • Magee Thomson Investment Partners reported no remaining Applied Genetic Technologies Corporation position as of Q3 2016 after selling out during the quarter.
  • Magee Thomson Investment Partners sold 44 Applied Genetic Technologies Corporation shares in Q3 2016, an estimated $1K.
  • Magee Thomson Investment Partners first reported a position in Applied Genetic Technologies Corporation in Q4 2014 and held it in 7 quarters.
  • Magee Thomson Investment Partners's Applied Genetic Technologies Corporation position peaked at $6K in Q1 2015.
  • 95 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q3 2016.

Based on Magee Thomson Investment Partners's 13F filing for Q3 2016, filed 27 Oct 2016.